Author

W. Van Loocke

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:ChIP-seq· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1

Frequent Co-Authors

P. Van Vlierberghe· 3 shared A. Louwagie· 2 shared B. Decaesteker· 2 shared C. Van Neste· 2 shared E. Sanders· 2 shared F. Speleman· 2 shared F. Van Nieuwerburgh· 2 shared M. Fischer· 2 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

P. Van Vlierberghe

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivMay 2, 2022

The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency

S. Wahlen, F. Matthijssens, W. Van Loocke…·G. Leclercq

This study shows that RUNX2 promotes human NK cell generation and tissue residency through IL-2Rβ induction, with implications for cancer therapy.

DOI 10.7554/elife.80320

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 25, 2020

RRM2 is a target for synthetic lethal interactions with replication stress checkpoint addiction in high-risk neuroblastoma

C. Nunes, L. Depestel, L. M. Mus…·F. Speleman

This study identifies RRM2 as a therapeutic target in high-risk neuroblastoma, showing that combined RRM2 and CHK1 inhibition synergistically reduces tumor growth.

DOI 10.1101/2020.11.25.397323

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 21, 2020

SOX11 is a lineage-dependency factor and master epigenetic regulator in neuroblastoma

B. Decaesteker, A. Louwagie, S. Loontiens…·F. Speleman

This study identifies SOX11 as a critical transcription factor and epigenetic regulator in adrenergic neuroblastoma, showing its role in chromatin accessibility and cell identity.

DOI 10.1101/2020.08.21.261131

humanDNA methylation

𝕏 PostBluesky